Point72 Asset Management, L.P.
Position in CRBU — Caribou Biosciences, Inc.
CIK 1603466
STAMFORD, CT
Position in CRBU
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$356,481
-$285,780 QoQ
Shares Held
187,622
-53.6% QoQ
Ownership
0.189%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 137 holders
Holding Since
Sep 2021
18 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRBU Over Time
Shares Held
Position Value (USD)
Derivatives in CRBU
reported options exposure · as of Sep 30, 2024CallValue
$196,000
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Point72 Asset Management, L.P. holds $2,393,298,297 across 187 Biotechnology names. CRBU ranks #150 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APLS |
Apellis Pharmaceuticals, Inc.
|
4,183,918 | $168,319,021 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
225,510 | $118,047,719 | |
| 3 | CLDX |
Celldex Therapeutics, Inc.
|
3,229,939 | $102,453,665 | |
| 4 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
846,801 | $73,646,282 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
424,750 | $71,791,245 | |
| 6 | ABVX |
Abivax S.A.
|
637,736 | $71,011,903 | |
| 7 | LEGN |
Legend Biotech Corp
|
3,886,017 | $70,298,047 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
358,634 | $67,799,757 |
All Filings in CRBU
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $356,481 | 187,622 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $642,261 | 403,938 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $672,314 | 288,547 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $365,071 | 289,739 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $208,972 | 228,885 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $1,629,732 | 1,024,989 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,177,579 | 2,131,418 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $196,000 | 100,000 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $3,843,405 | 2,343,540 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $18,426,992 | 3,585,018 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $20,177,484 | 3,521,376 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $16,729,201 | 3,499,833 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,231,390 | 289,739 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,538,514 | 289,739 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,819,560 | 289,739 | Shares | Defined | 2023-05-15 | |
| 2022-06-30 | $1,573,282 | 289,739 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,659,804 | 289,739 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,372,161 | 289,739 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,916,069 | 289,739 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||